Prometheus Biosciences, Inc

/Prometheus Biosciences, Inc

IPO

Prometheus Biosciences, Inc

Biotechnology

We are a biotechnology company pioneering a precision medicine approach to the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease (IBD).

Symbol

RXDX

Price Range
$18.00 - $19.00

Final Shares
9,000,000

Anticipated Date
March 12, 2021

Underwriters
LEERINK SWANN & COMPANY

This offering is no longer available

To view the prospectus for Prometheus Biosciences, Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange